Mechanism of resistance to the oncolytic C-nucleoside 2-β-D-ribofuranosylthiazole-4-carboxamide (NSC-286193)
作者： Hiremagalur N. Jayaram , David A. Cooney , Robert I. Glazer , Robert L. Dion , David G. Johns
DOI: 10.1016/0006-2952(82)90071-5
关键词:
摘要:
elsevier.com
sci-hub.se 参考文章(2)
R. K. Robins, P. C. Srivastava, V. L. Narayanan, J. Plowman, K. D. Paull, 2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases. Journal of Medicinal Chemistry. ,vol. 25, pp. 107- 108 ,(1982) , 10.1021/JM00344A002
ROBERT C. JACKSON, GEORGE WEBER, HAROLD P. MORRIS, IMP dehydrogenase, an enzyme linked with proliferation and malignancy Nature. ,vol. 256, pp. 331- 333 ,(1975) , 10.1038/256331A0